SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironments fiscal Q1 results beat expectations and its funded backlog reached a record, prompting renewed optimism about drone and counter-drone demand. Traders are divided because management maintained its full-year outlook, leaving concerns about growth, profitability and converting orders into revenue alongside the bullish reaction to the backlog.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters partnership with Seneca to integrate its Rev8 OS1 Max lidar into autonomous wildfire-response drones is drawing attention as a real-world autonomy use case. Traders are broadly upbeat about expanding lidar applications, while some question Ousters competitive moat and pricing as sensor costs fall.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers Investor Day is driving attention, with management reaffirming its outlook, outlining a long-term ARR ambition, and announcing an IBM/Red Hat security collaboration as analysts raised price targets. Traders welcomed the updates and AI-security opportunity, though some remain skeptical that the growth ambitions justify the valuation.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and upbeat outlook, followed by a wave of analyst upgrades, are driving attention. Traders are split between buyers expecting the growth story to support a recovery and sellers pointing to the sharp post-earnings pullback, profit-taking, and interest-rate concerns.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas recent rally has traders focused on increased Texas Cybercab registrations and stronger September Shanghai sales, while some are also positioning around an anticipated Roadster event. Bulls see momentum and expanding autonomy potential; bears argue the valuation is stretched and the move may fade.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Traders are using SQQQ to hedge or bet on a Nasdaq pullback, citing concerns about stretched tech and AI valuations, market breadth, and macro risks such as yields and geopolitical tensions. Others point to the Nasdaqs strength and warn that SQQQs leveraged, daily-reset structure can erode value, making it a risky longer-term hold.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Disruption and security risks around the Strait of Hormuz are the dominant focus, with traders linking constrained tanker traffic and elevated freight rates to BWETs exposure to tanker-freight futures. Bulls see the shipping squeeze as supportive, while bears warn that de-escalation could unwind rates quickly and point to the funds sharp, volatile run.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares are rebounding after a sharp selloff triggered by CEO CJ Desais abrupt departure to Meta, with traders describing the reaction as excessive and pointing to the former CEOs return as interim leader. Bulls also cite upbeat investor-day commentary, AI product launches and an expanded buyback, while skeptics remain concerned about leadership uncertainty and valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on CAN-2409s prostate-cancer trial and biomarker data, alongside Candels planned fourth-quarter 2026 BLA submission. Some traders view the immune findings and analyst upgrade as validation, while others question the filing timeline and raise concerns about management credibility, cash burn, and weak price action.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound and breakout attempts have fueled bullish momentum chatter, with traders pointing to Chainlinks institutional and tokenization integrations as support for its long-term infrastructure thesis. Others remain skeptical, citing weak or inconsistent price action and questioning whether network adoption will translate into value for the LINK token.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why McKesson (MCK) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Here's Why McKesson (MCK) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.

Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Here's Why McKesson (MCK) Fell More Than Broader Market

In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.

Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Option Care Stock Trades Below McKesson's Deal Price  Here's the Spread

Option Care Health agreed to a $5.8B buyout by CD&R and McKesson at $32.05 per share, pending shareholder and regulatory approvals.read more...

Why Option Care Health Stock Skyrocketed on Tuesday

Key PointsOption Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice...

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Mckesson Corporation

OPCH Stock Soars 22% After-Hours On $5B McKesson Buyout Talks

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$938.84
Prev Close	$930.25
Open	$927.56
Dividend Yield	0.37%
50-Day Moving Average	$883.72
Beta	0.02
Avg. Volume	860,873.67
PE Ratio	25.12

52-Week High	$999.00
52-Week Low	$723.68
Market Capitalization	$108.46B
EPS (Annual)	$38.37
Price to Book	-25.69
Revenue Per Employee	$9.38M

Feed

News

Sentiment

Earnings

Fundamentals

Info

MCK Fundamentals